CARTER PERCY H. (Chief Scientific Officer) sold 4.7% of their position (2.66K shares) of BLUEPRINT MEDICINES CORP on the open market
Open‑market sale worth $340.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/5/2025ACC: 0001415889-25-015767
Officer· Chief Scientific Officer
Since May 2021
-2.66K
Net shares
Net seller
$340.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−241.00
Price / share
$127.88
Trade value
$30.82K
% of position
0.4%
6/3/2025
56.87K→56.62K
Common Stock
Direct
Shares
−2.42K
Price / share
$127.88
Trade value
$309.21K
% of position
4.3%
6/3/2025
56.62K→54.21K
Total
Net shares
−2.66K
Net value
-$340.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2025 | S · Sale | −241.00 | $127.88 | $30.82K | 0.4% | 56.87K | 56.62K |
| Common Stock Direct | 6/3/2025 | S · Sale | −2.42K | $127.88 | $309.21K | 4.3% | 56.62K | 54.21K |
| Total | −2.66K | -$340.03K | ||||||
Derivative Transactions0
No derivative transactions reported